Treatment for rare brain tumors veers from traditional tack.
McBride
G
G
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D006727:Hormone Antagonists / Q000627:therapeutic use; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008577:Meningeal Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D008579:Meningioma / Q000188:drug therapy* / Q000503:physiopathology; D015735:Mifepristone / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D006727:Hormone Antagonists; D016898:Interferon-alpha; D015735:Mifepristone